Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00617695Phase 3Completed
A Phase 3 trial of zolmitriptan in migraine, sponsored by Impax Laboratories. Started Sep 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00617695.